2Dunaif A,Scott D,Finegood D,et al.The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome[J].Clin Endocrinol Metab,1996,81 (9):3299 -3306.
3Essah PA,Aorudonidze T,Iuomo MJ,et al.Effects of short-term and long-term meformin treatment on menstrual cyclicity in women with polyeystic ovary syndrome[J].Fertil Stefil,2006,86(1):230-232.
4Khorram O,Helliwell JP,Katz S,et al.Two weeks metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome[J].Fertil Steril,2006,85(5):1448-1451.
5Glueck CJ,Wang P,Fontaine RN,et al.Plasminogen activator inhibitor activity:an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome[J].Metabolism,1999,48:1589-1595.
6Glueck CJ.Pregnancy failure and preservation in women with polycystic ovary syndrome:safety and efficacy of metformin therapy continued through pregnancy[J].Exp Biol,2000,(4):16 -18.
7Seto -Young D,Paliou M,Schlosser J,et al.Direct thiazolidinedione action in the human ovary:insulin-independent and insulin-sensitizing effects on steroid genesis and insulin-like growth factor binding protein -1 production[J].J Clin Endocrinol Metab,2005,90 (11):6099 -6105.
8Sanaka M,Iwamoto Y.Troglitazone for treatment of polycystic ovary syndrome[J].Nippon Rinsho,2000,58(2):465.
9Garmes HM,Tambascia MA,Zantut -Wittmann DE.Endocrine -metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome[J].Gynecol Endocrinol,2005,21 (6):317 -323.
10Brettenthaler N,De Geyter C,Huber PR,et al.Effect of the insulin sensitizer pioglitazone on insulin resistance,hyperandrogenism,and ovulatory dysfunction in women with polycystic ovary syndrome[J].J Clin Endocrinol Metab,2004,89(8):3835 -3840.
